Secretariat invites comments on draft review of specific exemption for PFOI use to produce PFOB for pharmaceuticals (deadline 22 May 2026)

The Stockholm Convention Secretariat opened a comment process on a draft report reviewing the specific exemption for using perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for producing pharmaceutical products. The research text states a submission deadline of 22 May 2026. Compliance teams should assess whether they rely on (or may rely on) this exemption pathway and consider submitting technical input, as the review could affect continuation, conditions, or scope of the exemption.